monatepil has been researched along with prazosin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hosoki, K; Karasawa, T; Sugimoto, T | 1 |
Hosoki, K; Ikeno, A; Karasawa, T; Kato, H; Kurokawa, M; Masuda, Y; Minato, H; Yamada, T; Zushi, K | 1 |
Hosoki, K; Kondo, Y; Miyazaki, M; Nakano, K; Nomura, H; Notake, M | 1 |
Hosoki, K; Ikeno, A; Ishii, K; Miyazaki, M; Okazaki, Y; Okunishi, H | 1 |
Hosoki, K; Karasawa, T; Nakatsuji, K; Yamamoto, T | 1 |
Hayashi, K; Kajiyama, G; Kuga, Y; Kuwashima, J; Nomura, K; Nomura, S; Okura, Y; Shingu, T; Tanaka, K; Yasunobu, Y | 1 |
Floten, SH; He, GW; Liu, MH; Yang, Q | 1 |
7 other study(ies) available for monatepil and prazosin
Article | Year |
---|---|
Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Decerebrate State; Dibenzothiepins; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Hypotension; Injections, Intravenous; Piperazines; Prazosin; Rats; Rats, Wistar | 1995 |
Inhibitory effect of the new calcium antagonist AJ-2615 on progression of atherosclerosis in cholesterol-fed rabbits.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Cholesterol, Dietary; Dibenzothiepins; Diltiazem; Male; Phospholipids; Piperazines; Prazosin; Rabbits; Triglycerides | 1993 |
Up-regulation of hepatic LDL receptor gene expression by monatepil, a novel calcium antagonist, in high cholesterol diet-fed Japanese monkeys.
Topics: Animals; Calcium Channel Blockers; Cholesterol, Dietary; Dibenzothiepins; Female; Gene Expression; Liver; Macaca; Male; Piperazines; Prazosin; Receptors, LDL; RNA, Messenger; Up-Regulation | 1994 |
Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; Cholesterol, Dietary; Dibenzothiepins; Diet; Female; Heart Rate; Hypolipidemic Agents; Lipid Peroxidation; Lipids; Lipoproteins; Macaca; Male; Piperazines; Platelet Aggregation; Prazosin | 1994 |
Preventive effect of a new calcium antagonist, monatepil, on drug-induced ischaemic electrocardiographic changes in rats.
Topics: Administration, Oral; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Vasospasm; Dibenzothiepins; Electrocardiography; Heart Rate; Injections, Intravenous; Male; Methacholine Chloride; Myocardial Ischemia; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Rats, Wistar; Vasopressins | 1993 |
Inhibition of lipid hydroperoxidation of low density lipoprotein by the Ca(2+)-channel and alpha 1-adrenoceptor antagonist monatepil maleate.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anticholesteremic Agents; Calcium Channel Blockers; Copper; Copper Sulfate; Depression, Chemical; Dibenzothiepins; Diltiazem; Humans; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, LDL; Piperazines; Prazosin; Probucol | 1996 |
Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Calcium Channel Blockers; Coronary Artery Bypass; Dibenzothiepins; Dose-Response Relationship, Drug; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Mammary Arteries; Methoxamine; Middle Aged; Norepinephrine; Piperazines; Potassium Chloride; Prazosin; Serotonin; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2001 |